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failure to implant the coil, and by incomplete closure. We report a snare- 
assisted technique wh~l optimizes 0oil position for improved occlusion and 
minimizes dsk of embollzation. 
Mgthods:94 ptS (9.3-70.2 ym, median 3,3 yrs) underwent PDA occlusion 
using a snare-assisted approach. Minimum PDA diameter was 0,6--7.0 mm 
(median 2.3 ram), The snare was advanced to the main pulmonary artew 
(MPA) via the femoral vein to hold and manipulate the GC as it was delivered 
from the coil delivery catheter advanced across the PDA from the asrtio 
side. 1/4 loop of GC was inittally "sn~czed" on the MPA side of the PDA. With 
traction on the snare, the remaining coil IoOl~ were delivsrad to the aortic 
side. GC was then positioned optimally with the snare by pulling additional 
loop(s) to the MPA side and wedging them into the aodio ampulla. Prior to 
release, traction on the snore tested stability of GC posit}on, 
Results: GC placement was successful in 94/94 pts (100%) wi~ docu- 
mented complete closure in 86/94 (91A%). Immediate closure was observed 
in 75 by angingraphy and in 11 by echocardingraphy within 24 hours follow- 
ing coil implant. A single GC was used in 83/94 (88%) while 2-4 GCs were 
used in 11 patients. Snare was used to remove 1-6 GCs in 26/94 pts prior 
to snare release due to: GC slipping through PDA to MPA wi~ traction (5), 
LPA impingement (5), coil protrusion into aor~c lumen (4), other suboptimal 
cog position (9), inability to free coil from snare (3). In 3/94 (3.3%) pts, GC 
embotizocl to PA, but was retrieved in cath lab with sul0SeCluent successful 
duutal closure. There were no systemic embOlizations. 
Conclusion: The snere-ossisted elivery technique impmvas conb'ol of the 
GC ~ accuracy of its dalivety/placemenL 
~ Initial Clinical Experience Using the 
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Several devices have been developad for transcatheter vascular oc,'Jusion. 
These devices have limitations including inability tO adjust device posit}on, 
embolizaifon, and residual eaks. Wdh efforts to overcome these limitations, 
we report the first implants using the Gianturoo-Grifka Vascutsr occlusion 
device (GGVOD). The GGVOD consists of a nylon sack attached to an 
end-hole catheter; a filler wire is inserted through the catheter into the sack. 
In 8 lOtS, 10 vesSels were occluded using the GGVOD. Age ranged hem 2 
me to 35 yr (median 5.5 yr), weight ranged from 4.5 to 93 kg (median 21 kg). 
VeSsel diameter ranged from 4.3 to 6.2 rare (mean 5.3 ram). The GGVOD 
size chosen was 0.5-1.3 mm larger than the vesSel diamater. The vessels 
occluded were: Ao-PA collateral (3), PDA (2), SVC (2), intr~ulmena~y AVM 
(2), intracardiac i~ffle leak (1). fn 4 of 8 10is, prior to device release, the 
GC~VOD was ropositioned to a preferable location. In all vessels, the GGVOD 
was implanted without prebleros, resulting in complete o¢¢tssion. There were 
no device embotiZationa. 
In 2 pts with large vessels (9.2 mm azygous vein, 9.4 mm AVM), a 9 rare 
GGVOD was used to partially occlude the vessels, erKI to serve as a base 
upon which embolization coils were implanted. Both vessels were occluded 
completely. 
All pte had follow-up clinic evaluations 1 to 6 me post-GGVOD implant. 
There have been no late device embelizations or residual leaks, The PDA and 
Ao-PA collateral pts have decreased cardiomegaly and improved exercise 
teterance, 
Conclusion: The GGVOD can be ropositioned prior to release, affording 
safe and effective transsathater occlusion of tubular PDA, Ao-PA coifatereJ, 
AVM, SVC, and other vassals. 
~ Medium Term FOllow Up After Tninscatheter 
Umbrella Closure of  Perlmembmneaua Ventdoular 
Septal Defect p/SO) 
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From Oct 91-Sept 94, 17 infants and children underwent attempted tran- 
scalheter umbrella closure of a pedmerobraneous VSD, The procedure was 
unsuccess~l in 3 because the defect was too large. 2 patients required 
surgery, due to malposition (1) and severe aortic regurgitation (1) after 6 
months. 1 late death was unmtsted to the VSD closure. 10 of 11 remain- 
ing patients have undergone investigation to assess outcome 1 to 4 years 
(mean 1.6) later. On the electrocardiogram 6 have complefe (3) or partial 
(3) right bundle branch block. On 48 hour Holtsr all patients remain In si- 
nus rhythm without premature beats or taChysardla. With llanefhoroclc and 
transaesophagaal echooardiogrephy 4 patients had complete occlusion ef 
tl~ defect. The remaining 6 have small residual detects only. Mild and In- 
sigrdflcant ricuspid regurgitation was found In 4, The Doppler dedved right 
ventdculer systolic pressure from the VSD or tricuspid regurgitant velocity 
profiles waS 24-36 (mean 30 mmHg). Although none had evidence of left 
ventrioutar outflow tract obsfruclJon or aortic incompetence, apposition of 
the right coronary anrti¢ valve leaflet and the distal umbrella was evident 
in 4. At cardiac cathatedsation, small residual defects were confirmed in 6 
patients (mean QP:QS 1.9:1; mean pulmonary arterial systolic pressure 28 
mmHg), in conclusion. 1--4 years following umbrella closure of perimem- 
bransous VSD all patients are symptom free, right bundle branch block is 
frequestiy observed and a small residual VSD is present in more than half. 
Some patients appeared to have the potential to develop aortic regurgitation 
or aubaodio atanasis because of the position of the distal umbrella in the 
left venfricular outflow tract. Umbrella closure of a podmembmneous VSD 
cannot be recommended as a routine procedure. 
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In the USA, 24 patients have undergone closures with the Das ~" Angel 
Wings TM Imnssathater ASD closure device. (Secundum ASDs in 17, PFOs 
with presumed paradoxical cerebral embolism in 6, and 1 with residual 
shunting following ASD closure with the Clamshell" device). The patients 
were 21 ± 173 (mean =E SD) years old (range 3 to 75 yrs.) and. weighed 
56.1 :b 25.2 Kg. (range 14 to 111 Kg). The echaoerdiographic diameter 
of the defects was 9.0 :I: 5.7 ram. All patients with secundum ASDs had 
ech0cardiogrephic evidence of RV dilation and paradoxical motion of the 
IVS, 
ReJ;ults: N124 p~ents had a device successfully deployed. In 23 patients 
device waS deployed in the first attempt and in 1 patient a device deployed 
entirely into the LA was retrieved, followed by a seesnd successful closure. 
The balloon occlusive diameter leD), (minimum diameter of the balloon that 
could not be pulled through the defect), was 15,2 ~: 3.6 mm (range 10 to 
23 ram). The device (D) size used was 23.3 ± 3.6 mm (range 18 to 35 
mm). The D:OD ratio was 1.58 ± 0.24 (range 1.1 to 2.0). In 3 patients either 
the LA (n = 1) or P,A (n = 2) disk did hot open fully due to a large device 
size or suboptimal deployment. Transthoracic echocerdiography 24 hours 
later shm'~ad no shunting in 18, trivial (< 1 mm) in 3, small (1---2 ram) in 
1, moderato (3 ram) in 1, and large (>4 ram) in 1. Presence of residual 
small to large shunts was related to suboptimal deployment of the LA disk 
(n = 1) or a D:OD ratio <1.2 (n = 2). None of the devices embelized. There 
were no procedural complications. Conclusions: These results suggest hat 
trans,',athater closure of PFOs and ASDs with this new device is feasible and 
safe. 
~ Traoscetheler Closure of Secundum Atrial Septal 
Defects With the ASDOS Device in Chi ldren 
M. Schneider, U. Babio, B. F~ch,  G, Hausdorf. Char/~, Humboldt 
Universe, Berlin, Germany 
We report our in~al experence with the ~etar  occlusion of atdal sop- 
tat defects (ASD) in 15 children (body weight 12 to 42 kg) using the ASDOS 
device (Dr, Ing. Osy~a Coq~. Germany). The ASDOS device Consists of 
two umbrellas with a central body and rnte arms made out of nitinol, covered 
by a thin polyu~thaee patch. Both umbrellas am connected by screwing 
a Hit at the distal umbrella into ~e thrast of the proximal. Balloon sizing 
under transthora~ and tmnsesophagaal echocerdingrephio guidance was 
performed to measme the "slretched" diameter of the defect and a device 
witch deublad the size Of the defect was selected fur implantation, 
The "stre~eo" diameters of the defect ranged from 10 to 20 ram, the 
pufmOnic:-~syatemic bleed flow ratio from 1.5: ~. to 2.8:1. Trauscetheler ctO- 
sure was successhJily perlormed in 15 paflants using devices with a diameter 
ef~to4Omm. 
No significant complications were obasrvad udng this Inittal al~lications, 
During the follow~up aded of 2 to B months no dev~.ce mbolisations, throm- 
bcorobelio complisationL% abial padorations, paficardial effusions, atriovan- 
•cular valve dysfunctions or other complications occurred. Min{mal residual 
shunting (< 3 mm diameter) was observed in 3/15 patients. 
Desp~e our limited expadence and ~ow-op pe~od it can be concluded 
that this new device is a promising ~eter  approach for the osclusion 
of ASD's in children. 
~ Repeat Bal loon Aortic Valvuloplasty: Is It 
Worthwhile? 
David Shim, Thomas R. Lloyd, Robert H. Beekman IlL Division #pediatric 
Cat~l/otogy, G.S. Molt Cht7dmn's Hospital University of Michigan, Ann Arbor, 
Ul 
Restanosis has been obsewed following balloon aortic valvuioplasty (BAV), 
